How many insider trades does FilingIQ track for ACXP?

FilingIQ tracks 27 Form 4 insider transactions for ACXP (Acurx Pharmaceuticals, Inc.), covering filings from Jun 29, 2021 onwards. 8 of those were filed in the last 90 days.

Are ACXP insiders net buyers or net sellers?

Across the full Form 4 history for ACXP, 13 transactions (48%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ACXP insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ACXP in?

Acurx Pharmaceuticals, Inc. (ACXP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.34M.

ACXP insider trading

NasdaqCM Healthcare

Acurx Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

48% / 0%

Market cap

$6.34M

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Company website: www.acurxpharma.com

ACXP insider activity at a glance

FilingIQ has scored 27 insider transactions for ACXP since Jun 29, 2021. The most recent filing in our index is dated Apr 20, 2026.

Across the full history, 13 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ACXP insider trades is 55.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ACXP trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ACXP?: FilingIQ tracks 27 Form 4 insider transactions for ACXP (Acurx Pharmaceuticals, Inc.), covering filings from Jun 29, 2021 onwards. 8 of those were filed in the last 90 days.
Are ACXP insiders net buyers or net sellers?: Across the full Form 4 history for ACXP, 13 transactions (48%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ACXP insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ACXP in?: Acurx Pharmaceuticals, Inc. (ACXP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.34M.

Methodology & sources

Every ACXP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.